What does the future hold for brokers? Fast track to dustbin of history or cemented place in new marketplace?

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Private exchanges are here to stay, say Oliver Wyman’s Chris Bernene and Howard Lapsley. Five reasons why payers should double down on private exchange strategy.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

With their strategic control of data and money flow, payers have an opportunity to be the connective tissue for the new healthcare ecosystem.

Partner, Health and Life Sciences, Oliver Wyman

Earlier this week, on the same day, Gap announced it was closing 175 or 25% of its retail stores, while CVS Health proclaimed it was purchasing Target’s pharmacy and clinic business for $1.9 billion as part of an aggressive expansion push.

Partner, Health and Life Sciences, Oliver Wyman

Traditionally, visits to retail clinics were almost an entirely out-of-pocket expense. Now, as Forbes reports, retailers like CVS, Walgreens, and Wal-Mart are finding that the majority of their clinics’ visits are covered by insurance. Oliver Wyman’s Howard Lapsley puts this milestone into perspective.

Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe